25 December 2020>: Clinical Research
Elevated CA-125 Level and ER-Negative as Prognostic Factors for Ovarian Metastasis in Patients with Endometrial Cancer: A Retrospective Cohort Study
Xiaoting Ling 1ABCE* , Zheyu Zheng 2ABCE* , Jing Xu 1C , Guocai Xu 1F , Hui Zhou 1CD , Zhongqiu Lin 1F , Yangyang Li 3BDE , Jinxiao Liang 1AG* , Huaiwu Lu 1AD*DOI: 10.12659/MSM.928826
Med Sci Monit 2020; 26:e928826
Table 1 Patient, clinical, and pathological characteristics.
Varaible | No. of patients | % |
---|---|---|
Histological type | ||
Nonendometrioid | 66 | 11.68% |
Endometrioid | 499 | 88.32% |
Type | ||
Type II | 110 | 19.47% |
Type I | 455 | 80.53% |
Tubal involvement | ||
Yes | 42 | 7.43% |
No | 523 | 92.57% |
Myometrial invasion | ||
≥1/2 | 114 | 20.18% |
451 | 79.82% | |
LVSI | ||
LVSI+ | 60 | 10.62% |
LVSI− | 505 | 89.38% |
Lymph node metastasis | ||
Yes | 57 | 10.09% |
No | 508 | 89.91% |
Cervical extension | ||
Yes | 65 | 11.50% |
No | 500 | 88.50% |
Parametrial involvement | ||
Yes | 21 | 3.72% |
No | 544 | 96.28% |
Vaginal involvement | ||
Yes | 6 | 1.06% |
No | 559 | 98.94% |
Positive peritoneal washings/ascites | ||
Yes | 10 | 1.77% |
No | 555 | 98.23% |
Longest tumor diameter | ||
143 | 25.31% | |
2~5 | 234 | 41.42% |
>5 | 188 | 33.27% |
Age | ||
≥50 | 391 | 69.20% |
174 | 30.80% | |
Menopause | ||
Yes | 276 | 48.85% |
No | 289 | 51.15% |